GSA CAPITAL PARTNERS LLP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$308,000
+4.8%
14,568
-31.3%
0.04%
+9.1%
Q2 2019$294,000
+374.2%
21,200
+58.0%
0.03%
+560.0%
Q4 2013$62,000
-82.9%
13,419
-77.1%
0.01%
-82.8%
Q3 2013$362,000
-75.4%
58,538
-78.4%
0.03%
-83.3%
Q2 2013$1,471,000270,4900.17%
Other shareholders
IMMUNOMEDICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
RP Management, LLC 4,373,178$371,851,00055.73%
Avoro Capital Advisors LLC 26,250,000$2,232,038,00031.71%
Twin Securities, Inc. 467,761$39,774,00028.60%
Palo Alto Investors LP 4,852,383$412,598,00022.65%
Sand Grove Capital Management LLP 470,000$39,964,00021.19%
Beryl Capital Management LLC 1,046,632$88,995,00016.02%
Western Standard LLC 158,065$13,440,00015.26%
One68 Global Capital, LLC 60,990$5,186,00013.76%
First Light Asset Management, LLC 1,577,880$134,167,00013.75%
Boxer Capital, LLC 4,500,000$382,635,00013.22%
View complete list of IMMUNOMEDICS INC shareholders